Tag : Fremanezumab


Fremanezumab May Reduce Attacks in Tough-to-Treat Migraine

The CGRP-targeting migraine-prevention drug fremanezumab is safe and effective in reducing migraines for patients who have failed up to four other therapies, new research shows....
Latest News

Riassunto: Teva presenterà, al 19° congresso dell’International Headache Society, nuove analisi su efficacia e sicurezza di fremanezumab nei pazienti adulti affetti da emicrania difficile da trattare

GERUSALEMME–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE e TASE: TEVA) oggi ha annunciato di avere in programma la presentazione di oltre 30 analisi su fremanezumab in...
Latest News

Samenvatting: Teva presenteert nieuwe analyses van de werkzaamheid en veiligheid van Fremanezumab bij volwassen patiënten met moeilijk te behandelen migraine op het 19e congres van de International Headache Society

JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., een onderneming die zich bezighoudt met de productie en het gebruik van geneesmiddelen. (NYSE en TASE: TEVA) kondigde vandaag aan...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World